Lapatinib plus capecitabine in metastatic human epidermal growth factor receptor 2-positive breast cancer patients that received prior therapy with trastuzumab and pertuzumab: Better option than T-DM1?


Altundag K.

JOURNAL OF BUON, cilt.22, ss.281-282, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 22 Konu: 1
  • Basım Tarihi: 2017
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.281-282